Rocket Pharmaceuticals, Inc.
Income Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $14.9M | $6.0M |
| SG&A Expense | $4.9M | $1.6M |
| Operating Income | $-19.8M | $-7.6M |
| Operating Margin | — | — |
| Interest Expense | $0 | $0 |
| Pretax Income | — | — |
| Income Tax Expense | — | — |
| Net Income | $-19.6M | $-7.6M |
| Net Margin | — | — |
| EPS (Basic) | $-2.88 | $-1.11 |
| EPS (Diluted) | $-2.88 | $-1.11 |
| Shares Outstanding (Basic) | 6.8M | 6.7M |
| Shares Outstanding (Diluted) | 6.8M | 6.7M |
| Dividends Per Share | — | — |